Enterococcal gap

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Term indicating that cephalosporins have no effect against enterococci and listeria.

General informationThis section has been translated automatically.

Cephalosporins are β-lactam antibiotics that have a bactericidal effect by inhibiting the synthesis of the cell wall. Cephalosporins of the 1st generation (cefazolin) are mainly effective in the gram-positive range. With their further development (2nd generation: cefuroxime, 3rd generation: ceftriaxone (3a), ceftazidime (3b), 4th generation: cefepim, 5th generation: ceftarolin) the spectrum of activity has been extended into the gram negative range.

Cephalosporins bind to bacteria via structural proteins, the penicillin binding proteins, PBP. In Listeria monocytogenes the essential penicillin binding protein3, PBP3 and in all Enterococci the penicillin binding protein5, PBP5 is altered, so that cephalosporins are no longer effective.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer